Agilent Appoints New CEO
Agilent announces the appointment of Padraig McDonnell as CEO-elect and chief operating officer (COO), succeeding the incumbent President and CEO, Mike McMullen.
In a move poised to shape the future trajectory of Agilent Technologies Inc. (NYSE: A), the company has announced the appointment of Padraig McDonnell as CEO-elect and chief operating officer (COO), succeeding the incumbent President and CEO, Mike McMullen, who will retire. This significant leadership transition marks a pivotal moment for the well-known analytical and clinical laboratory technologies giant, headquartered in Santa Clara, California.
McDonnell, who is currently serving as the president of the Agilent CrossLab Group (ACG), will assume the role of president and CEO and join Agilent’s Board of Directors, effective May 1st. With nearly 40 years of dedicated service to Agilent and its predecessor Hewlett-Packard Co., McMullen will continue to serve as CEO and board member until the transition date. Subsequently, he will transition into an advisory role until his retirement on October 31st.
Koh Boon Hwee, chairman of Agilent’s Board of Directors, expressed confidence in McDonnell's capabilities, citing his successful tenure within Agilent. McDonnell has spearheaded exceptional growth in Agilent’s Services business and played a pivotal role in enhancing our customer’s experience, solidifying his reputation as a transformative leader within the organization.
McDonnell's ascent to the CEO role underscores Agilent’s commitment to continuity and growth. His extensive industry experience, coupled with a proven track record of driving innovation and profitability, positions him as a natural successor to McMullen. Under McMullen's leadership since 2015, Agilent witnessed substantial market capitalization growth, a testament to his strategic vision and operational prowess.
Reflecting on his forthcoming role, McDonnell expressed enthusiasm for the opportunity to lead Agilent into its next phase of development. He acknowledged McMullen’s mentorship and pledged to uphold Agilent’s legacy of innovation and customer-centricity.
Amidst these changes, Angelica Riemann will assume the role of ACG president, while Jonah Kirkwood will step into the position of chief commercial officer. Both will report directly to McDonnell, underscoring Agilent’s commitment to fostering internal talent and organizational continuity.
As Agilent embarks on this new chapter, McDonnell envisions a future brimming with possibilities and opportunities to further empower customers in their scientific achievements.
This article was written with the help of artificial intelligence and has been edited to ensure accuracy and clarity. You can read more about our policy for using AI here.
Reference
(1) Agilent Newsroom Home Page. https://www.agilent.com/about/newsroom/presrel/2024/21feb-gp24006.html (accessed 2024-02-26).
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
